Salix Sues Novel Labs Over Bowel Cleanser Patent

Law360, New York (May 15, 2008, 12:00 AM ET) -- Salix Pharmaceuticals Inc. has hit Novel Laboratories Inc. with a patent suit in a bid to maintain control over the U.S. market for MoviPrep, which is used for bowel cleansing prior to colonoscopies, intestinal surgery and barium enema X-ray exams.

Salix, Norgine BV and Norgine Europe BV filed their complaint on Wednesday in the U.S. District Court for the District of New Jersey. In December 2005, Salix struck a deal with Amsterdam-based Norgine under which Salix was granted the exclusive right to sell MoviPrep in the...
To view the full article, register now.